BioMarin Pharmaceutical Inc. buy Truist Financial Co.
Start price
13.07.23
/
50%
€76.16
Target price
13.07.24
€125.20
Performance (%)
-9.61%
Price
30.05.24
€68.80
Summary
This prediction is currently active. With a performance of -9.61%, the BUY prediction by Truist_Financial_Co_ is trending in the wrong direction. This prediction currently runs until 13.07.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
BioMarin Pharmaceutical Inc. | -1.178% | -1.178% |
iShares Core DAX® | -0.552% | 3.405% |
iShares Nasdaq 100 | -1.415% | 4.613% |
iShares Nikkei 225® | -0.877% | -1.396% |
iShares S&P 500 | -0.415% | 3.338% |
Comments by Truist_Financial_Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at Truist Financial Co. from $125.00 to $140.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€83.00
25.09.23
25.09.23
€131.92
25.09.24
25.09.24
-17.11%
30.05.24
30.05.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€82.68
15.09.23
15.09.23
€131.12
15.09.24
15.09.24
-16.79%
30.05.24
30.05.24